Nigeria's University of Ibadan,
has partnered with two American universities, and announced that they
have discovered a permanent cure for the sickle cell disease
On Wednesday, October 28th,
University of Ibadan in partnership with two American universities, announced
the discovery of a permanent cure for the sickle cell disease. The cure which was described as less
risky and with a potential to help over 5 million Africans living with the
disease, was the outcome of a research carried out by U.I in alliance with
medical experts at the University of Illinois and the University of Loyola,
both in Chicago. According to the Director of the
Sickle Cell Centre at the University of Illinois, Professor Victor Gordeuk, his colleague,
Prof. Damiano Rondelli, and Prof. Bamidele Tayo from the University of Loyola,
Chicago, the cure for the deadly disease, will be done through a bone marrow
transplant. The experts explained that unlike
the other conventional method of stem cell transplant which exposes patients to
radiation that could cause cancer, first blood and marrow stem cell transplant,
BMT, is much more effective. The Chief Medical Director, UCH,
Prof. Temitope Alonge, and two other doctors from the hospital: Dr. Titilola
Akingbola, a haematologist and Dr. Foluke Fasola, were also present at the
announcement of the cure. Professor Gordeuk said:
"With this chemotherapy-free transplant, we are curing adults with sickle
cell disease, and we see that their quality of life improves fast within just
one month of the transplant." He added, "In the new
procedure, patients receive immuno-suppressive drugs just before the
transplant, along with a very low dose of total body irradiation, a treatment
much less harsh and with fewer potentially serious side effects than
chemotherapy."
No comments:
Post a Comment
All comments represents the view of those who comment not that of the author